Insider · CIK 0001487815
Xiangmin Cui
Files at BYSI (BeyondSpring Inc.), AARD (Aardvark Therapeutics, Inc.), NUVB (Nuvation Bio Inc.). First filing -, latest -.
Xiangmin Cui files SEC Form 4 as 10% owner and director at BYSI (BeyondSpring Inc.), and also at AARD (Aardvark Therapeutics, Inc.), NUVB (Nuvation Bio Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Xiangmin Cui has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 21, 2026 | NUVB Nuvation Bio Inc. | AGrant or award Stock Option (Right to Buy)derivative | +123,397 | $0.00 | $0 | 123,397 | May 26, 2026 |
| Feb 27, 2026 | NUVB Nuvation Bio Inc. | AGrant or award Stock Option (Right to Buy)derivative | +76,923 | $0.00 | $0 | 76,923 | May 26, 2026 |
| Feb 27, 2026 | NUVB Nuvation Bio Inc. | AGrant or award Stock Option (Right to Buy)derivative | +74,813 | $0.00 | $0 | 74,813 | Mar 3, 2026 |
Questions about Xiangmin Cui
Answered from the filings on this page, as of the latest one.
Is Xiangmin Cui buying or selling?
Xiangmin Cui has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Xiangmin Cui's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Xiangmin Cui has 0.
Where does Xiangmin Cui file Form 4?
Xiangmin Cui has filed Form 4 at BYSI (BeyondSpring Inc.); AARD (Aardvark Therapeutics, Inc.); NUVB (Nuvation Bio Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.